Search information
ArriVent BioPharma, Inc. Common Stock
Companies
"Black"
Keywords
Tables in SEC filings
Source
| | | | | | |
| | Year Ended December 31, | ||||
| 2023 | 2022 | ||||
Risk-free interest rate | | 3.45% - 4.86% | | | 1.70% - 4.01% | |
Expected term | | 5.5 - 6.1 years | | 6 years | ||
Expected volatility | | 89.3% - 92.5% | | | 88.4% - 90.0% | |
Expected dividend yield | | — | | — | ||
Estimated fair value of the Company's common stock per share | | $ | 2.71 - 4.86 | $ | 2.28 |
Board Diversity Matrix (As of March 22, 2024) | ||||||||||||||
Board Size: | ||||||||||||||
Total Number of Directors | 6 | |||||||||||||
Female | Male | Non-Binary | Did not Disclose Gender | |||||||||||
Gender Identity: | ||||||||||||||
Directors | 1 | 4 | — | 1 | ||||||||||
Number of Directors Who Identify in Any of the Categories Below: | ||||||||||||||
African American or Black | — | — | — | — | ||||||||||
Alaskan Native or Native American | — | — | — | — | ||||||||||
Asian | — | 1 | — | — | ||||||||||
Hispanic or Latinx | — | — | — | — | ||||||||||
Native Hawaiian or Pacific Islander | — | — | — | — | ||||||||||
White | — | 2 | — | — | ||||||||||
Two or More Races or Ethnicities | — | — | — | — | ||||||||||
LGBTQ+ | — | |||||||||||||
Persons with Disabilities | — | |||||||||||||
Did Not Disclose Demographic Background | 3 |